Medicinova (MNOV) Live Share Price, Invest From India

Medicinova Stock Performance

as on September 18, 2026 at 1:13 am IST

Day's Low
Day's High
$2.83
Day's Price Range
$3.90
$3.36
15.77%
Downside
16.07%
Upside
52 Week's Low
52 Week's High
$1.17
52-Week Price Range
$2.62
$3.36
65.24%
Downside
-22.02%
Upside

Medicinova share price movements today

Previous Close: $2.52
Open: $2.88
Volume: 4.0M
Market Cap: $99.4M
Day's Low - High: $2.83 - $3.90
52 Week Low - High: $1.17 - $2.62

Medicinova Historical Returns

1 Month Return: + 90.91 %
3 Month Return: + 88.06 %
1 Year Return: + 106.56 %
3 Year Return: + 23.53 %
5 Year Return: -35.71 %

Medicinova Stock Fundamentals & Key Indicators

Check Medicinova market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$99.4M

EPS (TTM)

-0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

-0.94

EBITDA

-11.8M

Revenue (TTM)

920.5K

Profit Margin

0.00%

Return On Equity TTM

-25.56%

Medicinova vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Medicinova with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Medicinova	BUY	$99.4M	-35.71%	NA	0.00%	0.00%
Revolution Medicines	BUY	$43.9B	527.35%	NA	0.00%	0.00%
Vertex Pharmaceuticals	BUY	$130.4B	172.58%	29.71	86.04%	0.00%
Moderna	BUY	$57.4B	-66.14%	-18.02	-12.57%	0.00%
Regeneron	BUY	$81.7B	18.83%	18.48	84.86%	0.48%

Stock Returns calculator for Medicinova Stock including INR - Dollar returns

The Medicinova stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Medicinova investment value today

Current value as on today

₹3,01,101

Returns

₹2,01,101

(+201.1%)

Returns from Medicinova Stock

₹1,75,410 (+175.41%)

Dollar Impact

₹25,691 (+25.69%)

Analyst Recommendation on Medicinova Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Medicinova. Average target price of $9

Medicinova Share Price Target

Get share price movements and forecasts by analysts on Medicinova.

What analysts predicted

62.67%UPSIDE

Target Price

Current Price

$3.36

Analyzed by

2 Analysts

Target

$9.00

Medicinova target price $9, a slight upside of 62.67% compared to current price of $3.36. According to 2 analysts rating.

Indian Investors' Interest in Medicinova Stock

Search interest for Medicinova Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2026 to September 17, 2026

Change:7% versus previous 30 day period

Medicinova Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-3	-3	-3	-3	-3	-3	-3	-2	-2
EBITDA	-2	-2	-2	-2	-2	-3	-3	-2	-2	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-2	-2	-2	-3	-3	-2	-2	-2
Income Tax Expense	0	-	-	0	-	-	-	0	-	-
Net Income	-2	-2	-2	-2	-2	-3	-3	-2	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-2437.75%	-2473.56%	-1846.78%	-1383.14%	-504.79%

Medicinova Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	4	4	-	1	-	0
Gross Profit	0	0	0	0	0	4	0	1	0	0
Operating Income	-10	-13	-15	-14	-14	-10	-14	-9	-12	-13
EBITDA	-10	-12	-15	-14	-14	-10	-14	-8	-11	-11
Interest Expense	0	0	-	1	0	0	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-12	-14	-12	-13	-10	-14	-8	-11	-11
Income Tax Expense	0	-1	0	0	0	0	0	0	0	0
Net Income	-10	-11	-14	-12	-13	-10	-14	-8	-11	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-346.35%	-251.00%	0.00%	-857.15%	0.00%	-2928.78%

Medicinova Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	-2	-2	-2	-3	-3	-2	-2	-2,314
Operating Cash Flow	-2	-2	-1	-3	-2	-1	-2	-3	-1,920
Investing Cash Flow	0	0	0	-	-	0	-	0	-10
Financing Cash Flow	-	-	-	-	-	-	0	-	-
Change in Cash	-2	-2	-1	-3	-2	-1	-1	-3	-1,913

Medicinova Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-11	-14	-12	-13	-10	-14	-8	-11	-11
Operating Cash Flow	-6	-9	-9	-10	-9	-12	-7	-10	-9
Investing Cash Flow	-84	0	0	0	0	-40	39	0	0
Financing Cash Flow	10	42	10	7	20	0	32,461	-	0
Change in Cash	3	34	1	-3	11	-52	32	-10	-9

Mutual Funds that own Medicinova Stock

Check out the Mutual Funds with significant holdings in Medicinova.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	1.241413%	611039
Fidelity Concord Street Trust	0.883969%	435101
SCHWAB CAPITAL TRUST	0.145274%	71506
Bridgeway Funds, Inc.	0.102083%	50247

Global Institutional Holdings in Medicinova

Funds	Holdings
Vanguard	1.24%
iShares	0.32%
Bridgeway	0.1%

Insights on Medicinova

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MNOV stock has moved up by 44.8%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 375.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.1% return, outperforming this stock by 3.6%

About Medicinova

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Organisation	Medicinova
Headquarters	4275 Executive Square, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. Yuichi Iwaki M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Medicinova

Name	Title
Dr. Yuichi Iwaki M.D., Ph.D.	Co-Founder, President, CEO & Chairman
Dr. Kazuko Matsuda M.D., M.P.H., Ph.D.	Senior VP, Chief Medical Officer & Director
Dr. David H. Crean M.B.A., Ph.D.	Chief Business Officer
Mr. Jason J. Kruger CPA	CFO & Principal Financial Officer

FAQs

What is Medicinova share price today?

Medicinova share price today is $3.36 as on September 17, 2026 at 7:43 pm IST. Medicinova share today touched a day high of $3.90 and a low of $2.83.

What is the 52 week high and 52 week low for Medicinova share?

Medicinova share touched a 52 week high of $2.62 on September 16, 2026 and a 52 week low of $1.17 on October 30, 2025. Medicinova stock price today i.e. September 17, 2026 at 7:43 pm IST is trending at $3.36,which is -28.24% down from its 52 week high and 187.67% up from its 52 week low.

What is Medicinova's market capitalisation today?

Medicinova market capitalisation is $0.00T as on September 17, 2026 at 7:43 pm IST.

How to invest in Medicinova Stock (MNOV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Medicinova on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Medicinova Shares that will get you 0.4464 shares as per Medicinova share price of $3.36 per share as on September 17, 2026 at 7:43 pm IST.

What is the minimum amount required to buy Medicinova Stock (MNOV) from India?

Indian investors can start investing in Medicinova (MNOV) shares with as little as ₹95.93 or $1 (as of September 17, 2026 at 7:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Medicinova stock (as per the Rupee-Dollar exchange rate as on September 17, 2026 at 7:43 pm IST). Based on Medicinova share’s latest price of $3.36 as on September 17, 2026 at 7:43 pm IST, you will get 2.9762 shares of Medicinova. Learn more about fractional shares .

What are the returns that Medicinova has given to Indian investors in the last 5 years?

Medicinova stock has given -35.71% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?